Walking Fish Therapeutics, Inc.

 Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding about B cell trafficking.

Co-founded and led by Lewis “Rusty” Williams – a seasoned CEO with a successful track record of founding and growing biotech companies – Walking Fish Therapeutics has assembled a distinguished team of cell and engineering experts supported by world-renowned advisors and investors.  Our mission is to harness the therapeutic potential of human B cells to develop highly efficacious cell therapies.

You are cordially invited to join our vibrant team in South San Francisco, the birthplace of the Biotechnology industry.  In addition to exposure to cutting edges scientific concepts, you will have opportunities to gain hands-on experience on core techniques commonly used in CRISPR gene editing and cell therapy development in a supportive environment.

Berkeley Lights

Here at Berkeley Lights, we think cells are awesome! Cells are capable of manufacturing cures for diseases, fibers for clothing, energy in the form of biofuels, and food proteins for nutrition. So, the question is, if nature is capable of manufacturing the products we need in a scalable way, why aren’t we doing more of this? Well, the answer is that with the solutions available today, it is hard. Berkeley Lights is here to change all of that!

BLI is seeking a highly motivated and scientifically excellent candidate with experience in developing cell-based assays in immunology to join our Cell Therapy Development team. The candidate will work closely with our application, hardware, and software teams to establish cell therapy workflows using BLI state-of-art single-cell technologies.  This is a hands-on R&D position, where you will have the opportunity to create new capabilities on the Berkeley Lights Platform, taking products from early conception through product launch. As our organization encourages learning and personal development, you will find ample opportunities to increase your skillset and learn.

Applaud Medical

Applaud Medical is developing the next generation in treatments for biomineralization-related diseases such as urinary stone disease. The goal is to improve treatment methods, patient experiences and reduce medical costs in the US and all around the world.

The core technology consists of extracorporeal ultrasonic hardware which insonates catheter-placed microbubbles, nucleating cavitation to facilitate the fragmentation and passage of the biomineralization.

CAGE Bio Inc.

CAGE Bio Inc., currently a resident company at Johnson & Johnson Innovation, JLABS based at MBC BioLabs, CA and UNT, Fort Worth, TX, is a clinical-stage startup exploiting its proprietary deep eutectic ionic liquid platform to develop novel products for infection, inflammation, and immunology. Deep eutectic ionic liquids exhibit broad-spectrum antimicrobial action in addition to exceptional solvation and permeation enhancement. Our mission is to develop highly effective products for localized treatment thereby minimizing side effects from systemic exposure.

We focus on developing topical drug products with highly insoluble small molecules as well as with macromolecules such as oligonucleotides and peptides to treat various therapeutic indications. 

The student will be working closely with our R&D team in San Carlos, CAon developing drug product formulations to exploit our deep eutectic ionic liquid platform.

Big Hat

BigHat Biosciences aims to radically reduce the difficulty of designing antibodies and other therapeutic proteins.
Their AI-first experimental platform integrates a high-speed wet lab with artificial intelligence / machine learning (AI/ML) techniques and enables drug developers to create better antibodies faster and undertake novel biotherapeutic designs far beyond what’s possible today.

Wild Type

Wild Type mission is to create the cleanest, most sustainable fish and meat on the planet. To address the pressing challenges of our generation: climate change, food security, and health.

ENCELLIN

Helping implanted cells survive in the body. A team of dedicated experts focused on the investigation and advancement of next-generation therapies. Determined to help patients with chronic diseases, starting with Type 1 diabetes.

Encellin expects their fall activities to include:

• Clinical trial planning and management

• New submissions to the FDA (outside diabetes)

• Quality systems management

• Animal studies including surgery

• 3D imaging and reconstruction

• Histology/pathology

ELEGEN

Elegen is developing a high-throughput microfluidic oligosynthesizer, oligo assembler, and cell-free molecular cloning system. The oligosynthesizer is a benchtop instrument using microfluidics, fluidics, optics, machine vision, and organic chemistry to build 10,000 short DNA molecules (oligos) at once.

Soteria Biotherapeutics

Soteria is developing next-generation immunotherapies with improved efficacy and safety.

Pivotal bioVenture Partners

Pivotal bioVenture Parters is a Venture Capital investor focused on innovative therapeutic products and platforms to address major unmet medical needs. 

Become part of their team that brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.

rumi scientific

Rumi’s technology is a powerful engine for the discovery of novel therapeutics. And Rumi is uniquely positioned to treat neurodevelopmental disorders with its leading-edge science.

Siolta Therapeutics

Siolta Therapeutics mission is to develop novel microbiome-based therapeutics and companion diagnostics aimed at the prevention and treatment of chronic diseases.

Sentieon

Sentieon develops and supplies a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency, fast turnaround time, exceptional accuracy, and 100% consistency.

Madorra

Madorra is working towards changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. We are focused on giving post-menopausal women and breast cancer survivors the power to choose the non-hormonal treatment option they want.

GraftWorx

We are a clinical stage medical technology company enabling precision medicine with real-time data. The only technology platform monitoring clinically actionable hemodynamic parameters, continuously and non-invasively, to detect early warning signs of serious events and avoid preventable hospital visits.

Juvena THERAPEUTICS

Juvena is a biopharma startup developing protein-based tissue rejuvenation therapeutics to help people live healthier, longer